Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

San Diego???s Flourishing Industrial Biotech Sector Provides The Backdrop ForBiotechnology Industry Organization (BIO)???s 2014 Pacific Rim Summit On Industrial Biotech & Bioenergy

October 15, 2014 – 5:00 am | Edit Post

With a growing industrial biotech sector that is home to more than 400 biotechnology companies, San Diego is set to host BIOs 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy. San Diego-based industrial biotechnology companies continue to deliver next generation products and innovative technology solutions, many of which will be highlighted during the programming at this years Summit. The…

UBS: Gilead Sciences, Inc. Remains Solid Buy Despite Irish Tax Changes, Price War

October 15, 2014 – 5:00 am | Edit Post

Illumina, Inc. Picks Three Companies For Accelerator Funding Cycle

October 15, 2014 – 5:00 am | Edit Post

Illumina Accelerator Announces Investment in Inaugural Startup ClassInitial Companies Focused on Breakthrough Applications in Therapeutics, Agriculture, and Molecular PathologySAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (ILMN) today announced the selection of three startup companies for the inaugural Illumina Accelerator funding cycle. The…

<i>Harvard Business Review</i> Ranks <b>David Pyott</b> One Of The Top 5 CEOs In The World

October 15, 2014 – 5:00 am | Edit Post

IRVINE, Calif.–(BUSINESS WIRE)–Allergan, Inc.s (NYSE: AGN) (the Company) Chairman of the Board and Chief Executive Officer, David E.I. Pyott, has been ranked the 4th best-performing CEO in the world by the Harvard Business Review (HBR). Mr. Pyott was selected for this honor out of a total of 832 current CEOs in 30 countries who qualified for consideration by HBR. The complete list, which has been…

Sorrento Therapeutics, Inc. Release: Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel

October 15, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 14, 2014 /PRNewswire/ –Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced today positive results from recently analyzed pharmacokinetic (PK) data from the first eight (8) patients enrolled in its…

Could Vitamin D Make Childbirth Less Painful? Cedars-Sinai Medical Center Study

October 15, 2014 – 5:00 am | Edit Post

Low vitamin D levels could make childbirth more painful, according to a new study. Vitamin D deficiency is common during pregnancy, especially among high-risk women, including vegetarians, those with little sun exposure, and members of ethnic minorities, the American College of Obstetricians and Gynecologists says. The new study included 93 pregnant women whose vitamin D levels were checked before…

Illumina, Inc. Release: Announces Investment In Inaugural Startup Class

October 15, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced the selection of three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics, Inc., EpiBiome, Inc., and Xcell Biosciences Inc. The Illumina Accelerator is the worlds first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It…

NeuroSigma, Inc. And The Enter Into Cooperative Research And Development Agreement (CRADA)

October 15, 2014 – 5:00 am | Edit Post

LOS ANGELES, Oct. 15, 2014 /PRNewswire/ –NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System…

VG Life Sciences, Inc. Announces SEC Form 10 Review Complete

October 15, 2014 – 5:00 am | Edit Post

SANTA BARBARA, Calif., Oct. 14, 2014 (GLOBE NEWSWIRE) — VG Life Sciences Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune and infectious diseases. VG Life Sciences is pleased to announce the Securities & Exchange Commission…

Adamis Pharmaceuticals Announces Key Additions To Medical And Commercial Teams

October 15, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 15, 2014 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) today announced key additions…